STOCK TITAN

Core Scientific (CORZ) awards 27,594 RSUs to director Mark Adams

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Adams Mark reported acquisition or exercise transactions in this Form 4 filing.

Core Scientific, Inc. reported that director Mark Adams received a grant of 27,594 restricted stock units of common stock on July 30, 2026. These RSUs vest in two equal installments on July 30, 2027 and July 30, 2028, contingent on his continued service, resulting in direct ownership of 27,594 units.

Positive

  • None.

Negative

  • None.
Insider Adams Mark
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 27,594 $0.00 $0.00
Holdings After Transaction: Common Stock — 27,594 shares (Direct)
Footnotes (1)
  1. F1. Represents a restricted stock unit ("RSU") grant. The RSUs will vest in two equal installments on July 30, 2027 and July 30, 2028, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.
RSU grant size 27,594 units Restricted stock units granted to Mark Adams on 2026-07-30
Total common stock equivalents after grant 27,594 units Direct non-derivative holdings reported following the award
Vesting installments 2 RSUs vest in two equal installments if service continues
Vesting dates July 30, 2027 and July 30, 2028 Service-based vesting schedule for the RSU grant
restricted stock unit financial
"Represents a restricted stock unit ("RSU") grant."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vest financial
"The RSUs will vest in two equal installments on July 30, 2027 and July 30, 2028"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Reporting Person financial
"provided that the Reporting Person continues to provide service to the Issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity award did Mark Adams receive from Core Scientific (CORZ)?

Mark Adams received a grant of 27,594 restricted stock units (RSUs) of Core Scientific common stock on July 30, 2026. The RSUs are a stock-based compensation award that can convert into shares as they vest over time, subject to service conditions.

When do Mark Adams's CORZ restricted stock units vest?

The 27,594 RSUs granted to Mark Adams vest in two equal installments on July 30, 2027 and July 30, 2028. Each vesting date requires that he continue providing service to Core Scientific through that specific vesting date.

Is Mark Adams's recent CORZ transaction a market purchase or a grant?

The reported CORZ transaction is a grant of restricted stock units, not a market purchase. The Form 4 identifies the transaction as a grant or award acquisition, with a per-unit price of $0.00, typical for equity compensation awards.

How many Core Scientific (CORZ) units does Mark Adams hold after this grant?

After the July 30, 2026 RSU grant, Mark Adams holds 27,594 common stock equivalent units directly. This figure reflects the total non-derivative holdings reported following the award, assuming the RSUs are reported as common stock equivalents on the form.

What conditions apply to the vesting of Mark Adams's CORZ RSUs?

The 27,594 RSUs vest only if Mark Adams continues to provide service to Core Scientific. Vesting occurs in two equal installments on July 30, 2027 and July 30, 2028, so leaving the company before a vesting date would forfeit unvested units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Adams Mark

(Last)(First)(Middle)
C/O CORE SCIENTIFIC, INC.
838 WALKER ROAD, SUITE 21-2105

(Street)
DOVER DELAWARE 19904

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026A27,594(1)A$027,594D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") grant. The RSUs will vest in two equal installments on July 30, 2027 and July 30, 2028, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.
/s/ Todd DuChene, as Attorney-in-Fact08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)